Insider · CIK 0001825776

Schambye Hans T.

Reports to the SEC for 1 company · COPENHAGEN N G7, G7

sec.gov

Transactions

Companies

Filings

CIK

0001825776

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	DMRADamora Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,360 sh	—	—	5,382
2026-01-02	DMRADamora Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−700 sh	$21.38	−$15K	4,682
2026-01-02	DMRADamora Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,360 sh	—	—	2,640
2025-07-03	DMRADamora Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,360 sh	—	—	4,757
2025-07-03	DMRADamora Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−735 sh	$3.38	−$2,484.3	4,022
2025-07-03	DMRADamora Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,360 sh	—	—	4,000
2025-01-03	DMRADamora Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,640 sh	—	—	4,738
2025-01-03	DMRADamora Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,341 sh	$5.60	−$7,509.6	3,397
2025-01-03	DMRADamora Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−2,640 sh	—	—	5,360
2025-01-03	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+16.4K sh	—	—	16,400
2024-10-09	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+44.1K sh	—	—	44,100
2024-01-03	DMRADamora Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000
2023-01-04	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2022-03-22	DMRADamora Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$2.15	+$10.8K	52,428
2022-01-04	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+288K sh	—	—	287,500
2021-11-09	DMRADamora Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,500 sh	$3.50	+$15.8K	47,428
2021-06-24	DMRADamora Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,000 sh	$5.11	+$15.3K	42,928
2021-01-05	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+230K sh	—	—	230,000
2020-11-02	DMRADamora Therapeutics, Inc.C Conversion	Director, Chief Executive Officer	CConversion	+13.9K sh	—	—	39,928
2020-11-02	DMRADamora Therapeutics, Inc. · Series C-1 Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−5,359 sh	—	—	0
2020-10-07	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+520K sh	—	—	519,940
2020-06-24	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+208K sh	—	—	207,976

Recent filings

Accepted (ET)
Jan 64
Schambye Hans T.0001193125-26-004573
SEC(opens sec.gov)
Jul 84
Schambye Hans T.0000950170-25-094576
SEC(opens sec.gov)
Jan 74
Schambye Hans T.0000950170-25-002811
SEC(opens sec.gov)
Oct 114
Schambye Hans T.0000950170-24-114384
SEC(opens sec.gov)
Jan 54
Schambye Hans T.0000950170-24-002433
SEC(opens sec.gov)
Jan 54
Schambye Hans T.0001209191-23-001760
SEC(opens sec.gov)
Mar 234
Schambye Hans T.0001209191-22-020682
SEC(opens sec.gov)
Jan 64
Schambye Hans T.0001209191-22-002215
SEC(opens sec.gov)
Nov 104
Schambye Hans T.0001209191-21-063798
SEC(opens sec.gov)
Jun 244
Schambye Hans T.0001209191-21-042986
SEC(opens sec.gov)
Jan 74
Schambye Hans T.0001209191-21-002476
SEC(opens sec.gov)
Nov 44
Schambye Hans T.0000899243-20-030412
SEC(opens sec.gov)

Companies

Damora Therapeutics, Inc.Director, Chief Executive OfficerDMRA

Address

OLE MAALOES VEJ 3 C/O GALECTO, INC.

COPENHAGEN N G7, G7, DK-2200